Filing Details
- Accession Number:
- 0001209191-16-121395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-18 17:55:34
- Reporting Period:
- 2016-05-16
- Filing Date:
- 2016-05-18
- Accepted Time:
- 2016-05-18 17:55:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621334 | Pat Cotroneo | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Vp, Finance And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-05-16 | 6,107 | $17.60 | 141,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $17.35 to $17.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 1,389 shares purchased through the issuer's employee stock purchase plan on May 13, 2016.
Billionaire Hedge Funds
